Gilead, Galapagos amend commercialisation and development pact for Jyseleca (filgotinib) EP News Bureau Dec 16, 2020 Under the new arrangement, Galapagos will assume sole responsibility in Europe for filgotinib in RA, Gilead to receive royalties…
Gilead gets approval for Jyseleca (filgotinib) in Japan for rheumatoid arthritis EP News Bureau Sep 25, 2020 Gilead Japan will hold marketing authorisation of Jyseleca in Japan while Eisai will be responsible for product distribution
US FDA declines approval for Gilead’s rheumatoid arthritis drug, Filgotinib EP News Bureau Aug 20, 2020 The US drug regulator has issued a complete response letter requesting data from the MANTA and MANTA-RAy studies and expressing…
Higher dose of Gilead-Galapagos drug meets ulcerative colitis study goals Reuters May 22, 2020 Filgotinib is also in advanced stages of testing against multiple types of inflammatory conditions including rheumatoid arthritis,…